Sekizawa A - Search Results

1

Cell-free fetal DNA in the plasma of pregnant women with severe fetal growth restriction.

Sekizawa A, Jimbo M, Saito H, Iwasaki M, Matsuoka R, Okai T, Farina A. Sekizawa A, et al. Am J Obstet Gynecol. 2003 Feb;188(2):480-4. doi: 10.1067/mob.2003.27. Am J Obstet Gynecol. 2003. PMID: 12592259

2

Increased cell-free fetal DNA in plasma of two women with invasive placenta.

Sekizawa A, Jimbo M, Saito H, Iwasaki M, Sugito Y, Yukimoto Y, Otsuka J, Okai T. Sekizawa A, et al. Clin Chem. 2002 Feb;48(2):353-4. Clin Chem. 2002. PMID: 11805017 No abstract available.

3

Testing normality of fetal DNA concentration in maternal plasma at 10-12 completed weeks' gestation: a preliminary approach to a new marker for genetic screening.

Farina A, Caramelli E, Concu M, Sekizawa A, Ruggeri R, Bovicelli L, Rizzo N, Carinci P. Farina A, et al. Among authors: sekizawa a. Prenat Diagn. 2002 Feb;22(2):148-52. doi: 10.1002/pd.262. Prenat Diagn. 2002. PMID: 11857623

4

Fate of fetal nucleated erythrocytes circulating in maternal blood: apoptosis is induced by maternal oxygen concentration.

Kondo T, Sekizawa A, Saito H, Jimbo M, Sugito Y, Okai T. Kondo T, et al. Among authors: sekizawa a. Clin Chem. 2002 Sep;48(9):1618-20. Clin Chem. 2002. PMID: 12194953 No abstract available.

5

p53 mutations and overexpression affect prognosis of ovarian endometrioid cancer but not clear cell cancer.

Okuda T, Otsuka J, Sekizawa A, Saito H, Makino R, Kushima M, Farina A, Kuwano Y, Okai T. Okuda T, et al. Among authors: sekizawa a. Gynecol Oncol. 2003 Mar;88(3):318-25. doi: 10.1016/s0090-8258(02)00149-x. Gynecol Oncol. 2003. PMID: 12648581

6

Evaluation of bidirectional transfer of plasma DNA through placenta.

Sekizawa A, Yokokawa K, Sugito Y, Iwasaki M, Yukimoto Y, Ichizuka K, Saito H, Okai T. Sekizawa A, et al. Hum Genet. 2003 Sep;113(4):307-10. doi: 10.1007/s00439-003-0987-4. Epub 2003 Jul 23. Hum Genet. 2003. PMID: 12884005

7

Placenta increta: Postpartum monitoring of plasma cell-free fetal DNA.

Jimbo M, Sekizawa A, Sugito Y, Matsuoka R, Ichizuka K, Saito H, Okai T. Jimbo M, et al. Among authors: sekizawa a. Clin Chem. 2003 Sep;49(9):1540-1. doi: 10.1373/49.9.1540. Clin Chem. 2003. PMID: 12928242 No abstract available.

8

Relationship between severity of hyperemesis gravidarum and fetal DNA concentration in maternal plasma.

Sugito Y, Sekizawa A, Farina A, Yukimoto Y, Saito H, Iwasaki M, Rizzo N, Okai T. Sugito Y, et al. Among authors: sekizawa a. Clin Chem. 2003 Oct;49(10):1667-9. doi: 10.1373/49.10.1667. Clin Chem. 2003. PMID: 14500595 No abstract available.

9

Proteinuria and hypertension are independent factors affecting fetal DNA values: a retrospective analysis of affected and unaffected patients.

Sekizawa A, Farina A, Sugito Y, Matsuoka R, Iwasaki M, Saito H, Okai T. Sekizawa A, et al. Clin Chem. 2004 Jan;50(1):221-4. doi: 10.1373/clinchem.2003.023259. Clin Chem. 2004. PMID: 14709656 No abstract available.

10

Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low-risk nonsymptomatic patients.

Farina A, Sekizawa A, Sugito Y, Iwasaki M, Jimbo M, Saito H, Okai T. Farina A, et al. Among authors: sekizawa a. Prenat Diagn. 2004 Feb;24(2):83-6. doi: 10.1002/pd.788. Prenat Diagn. 2004. PMID: 14974111

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

359 results

Search Page

Filters